Sci-Tech Innovation Board Healthcare ETF Huaxia (588130) offers retail investors a low-threshold gateway to the STAR Market healthcare sector

Industry
โดย Choice·Read original
Summary · why it matters

Sci-Tech Innovation Board Healthcare ETF Huaxia (588130) provides an alternative low-threshold path for retail investors who do not meet the account opening requirements for the STAR Market to participate in the board's biomedical sector. The ETF does not require STAR Market trading permissions; investors only need an ordinary A-share account or an on-exchange fund account to buy on the secondary market. The minimum trading unit is 100 shares, which at recent market prices amounts to around 100 yuan, whereas buying individual STAR Market stocks directly requires a minimum of 200 shares, often costing tens of thousands of yuan. The 588130 ETF tracks the SSE STAR Market Biomedical Index, offering one-click exposure to the top 50 biomedical companies by market capitalization on the STAR Market. The top ten holdings account for over 51% of the total, covering leaders in niche segments such as United Imaging Healthcare, BeiGene, and Allist Pharmaceuticals, with no single constituent exceeding 10% weight, balancing representation of leaders with risk diversification. As of July 16, 2026, the ETF's latest float size reached 323 million yuan, a new high over the past year, with an average daily turnover of 40.7485 million yuan over the last 20 trading days.

Impact on stocks 4

Others▲ · 4 stocks
BeiGene Ltd.
688235
± Mixedrelevance

Listed as a top holding in the ETF, but no company-specific news; ETF structure provides indirect exposure.

© 2026 MarketDXNews